Clinical Trial Update: PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing PD-1 inhibitor therapy to radiotherapy in patients with locally advanced head and neck squamous cell carcinoma after neoadjuvant immun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor therapy

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: HNSCC, Radiotherapy | Phase 3 | Status: RECRUITING